Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Auvelity as Adjunctive Treatment for Opioid Use Disorder
NCT05976646Phase 2Completed
- Sponsor
- Virginia Commonwealth University
- Start
- Sep 2023
- Primary completion
- Jul 2025
- Countries
- 1
01
Overview
A Phase 2 trial of dextromethorphan + bupropion in opioid use disorder (OUD), sponsored by Virginia Commonwealth University. Started Sep 2023; status: completed.
02
Drugs
dextromethorphan + bupropion
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT05976646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05976646.